Celgene Corporation (CELG): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Celgene Corporation ( CELG) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 0.5%. By the end of trading, Celgene Corporation fell $3.31 (-2.1%) to $152.62 on average volume. Throughout the day, 2,718,491 shares of Celgene Corporation exchanged hands as compared to its average daily volume of 2,519,200 shares. The stock ranged in price between $150.46-$155.95 after having opened the day at $155.50 as compared to the previous trading day's close of $155.93. Other companies within the Health Care sector that declined today were: Mast Therapeutics ( MSTX), down 33.1%, Delcath Systems ( DCTH), down 11.9%, Zalicus ( ZLCS), down 11.7% and DARA Biosciences ( DARA), down 10.8%.

Celgene Corporation discovers, develops, and commercializes therapies for cancer and immune-inflammatory related diseases in the United States and Europe. Celgene Corporation has a market cap of $60.2 billion and is part of the drugs industry. Shares are up 86.6% year to date as of the close of trading on Wednesday. Currently there are 20 analysts that rate Celgene Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Celgene Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, notable return on equity and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the positive front, GW Pharmaceuticals PLC ADR ( GWPH), up 132.5%, Idera Pharmaceuticals ( IDRA), up 24.4%, Edap TMS ( EDAP), up 22.1% and Omeros Corporation ( OMER), up 18.2% , were all gainers within the health care sector with Questcor Pharmaceuticals ( QCOR) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

What Angela Merkel's Uncertain Political Future Means for Greece's Debt Woes

What Angela Merkel's Uncertain Political Future Means for Greece's Debt Woes

China Central Bank Governor Says Stay 'Calm and Rational' After Market Free Fall

China Central Bank Governor Says Stay 'Calm and Rational' After Market Free Fall

50 Stocks Goldman Sachs Thinks Can Triumph Over Labor Inflation

50 Stocks Goldman Sachs Thinks Can Triumph Over Labor Inflation

Trump Issues New Trade Threats, Apple, ZTE, GameStop - 5 Things You Must Know

Trump Issues New Trade Threats, Apple, ZTE, GameStop - 5 Things You Must Know

China-Focused Stocks Hit Hard as Beijing Responds to Trump Tariff Threats

China-Focused Stocks Hit Hard as Beijing Responds to Trump Tariff Threats